by Admin Neo Lumina | Nov 7, 2025 | Press Release
NeoLumina Partners with Catalent to Pioneer Psilocin Delivery, Marking a Major Leap in Psychedelic Med for Mental Health Pioneering Precision: NeoLumina and Catalent Partner to Redefine Psilocin Delivery for Mental Health Treatment. VANCOUVER, BRITISH COLUMBIA,...
by Admin Neo Lumina | Oct 22, 2025 | News
From Breakthrough to Transformation: Redefining What’s Possible in Mental Health Treatment A single clinical breakthrough changed everything for treatment-resistant depression. Now, NeoLumina is taking that science to a new frontier — applying it to conditions like...
by Admin Neo Lumina | Oct 21, 2025 | News
New law to speed study of psychedelics for mental health By Clara Harter (Source: Los Angeles Times)Gov. Gavin Newsom recently signed a bill to fast-track the study of psychedelic drugs that hold enormous potential to treat post-traumatic stress disorder and...
by Admin Neo Lumina | Oct 17, 2025 | News
Moving Forward with Purpose: NeoLumina Prepares for Phase 2 Clinical Trial in Binge Eating Disorder NeoLumina BioScience advances its mission to redefine mental health treatment through science, conviction, and collaboration — preparing to launch a Phase 2 clinical...
by Admin Neo Lumina | Oct 14, 2025 | News
Breaking the Cycle: A New Path Forward for Eating Disorder Treatment Eating disorders are complex, deadly, and often intertwined with other physical and mental health challenges. NeoLumina is committed to creating a new way forward — one rooted in nature, science, and...
